Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

被引：63

作者：

Furst, D. E.

Breedveld, F. C.

Kalden, J. R.

Smolen, J. S.

Burmester, G. R.

Emery, P.

Keystone, E. C.

Schiff, M. H.

van Riel, P. L. C. M.

Weinblatt, M. E.

Weisman, M. H.

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA

[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands

[3] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, D-8520 Erlangen, Germany

[4] Vienna Gen Hosp, Inst Rheumatol, Clin Internal Med 3, Vienna, Austria

[5] Charite Hosp, Dept Rheumatal & Clin Immunol, Berlin, Germany

[6] Univ Leeds, Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England

[7] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON M5G 1X5, Canada

[8] Denver Arthrit Clin, Denver, CO USA

[9] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[10] Brigham & Womens Hosp, Boston, MA 02115 USA

[11] Cedar Sinai Hosp, Los Angeles, CA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷

关键词：

D O I：

10.1136/ard.2006.061937

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 15

页数：14

共 264 条

[81] Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade [J].

Feinstein, J ;

Arroyo, R .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (04) :219-222

[82] Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients [J].

Feletar, M ;

Brockbank, JE ;

Schentag, CT ;

Lapp, V ;

Gladman, DD .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) :156-161

[83] Tumor necrosis factor inhibition and invasive fungal infections [J].

Filler, SG ;

Yeaman, MR ;

Sheppard, DC .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S208-S212

[84] Rapid responses to anakinra in patients with refractory adult-onset Still's disease [J].

Fitzgerald, AA ;

LeClercq, SA ;

Yan, A ;

Homik, JE ;

Dinarello, CA .

ARTHRITIS AND RHEUMATISM, 2005, 52 (06) :1794-1803

[85] Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis [J].

Fleischmann, R ;

Stern, R ;

Iqbal, I .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) :1333-1344

[86]

FLEISCHMANN R, 2005, ARTHRITIS RHEUM, V52, P263

[87] Safety of extended treatment with anakinra in patients with rheumatoid arthritis [J].

Fleischmann, R. M. ;

Tesser, J. ;

Schiff, M. H. ;

Schechtman, J. ;

Burmester, G-R ;

Bennett, R. ;

Modafferi, D. ;

Zhou, L. ;

Bell, D. ;

Appleton, B. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :1006-1012

[88] Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis - A large, international, multicenter, placebo-controlled trial [J].

Fleischmann, RM ;

Schechtman, J ;

Bennett, R ;

Handel, ML ;

Burmester, GR ;

Tesser, J ;

Modafferi, D ;

Poulakos, J ;

Sun, G .

ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :927-934

[89]

Fleischmann Roy M, 2004, Expert Opin Drug Saf, V3, P391, DOI 10.1517/14740338.3.5.391

[90]

Furst DE, 1999, RHEUMATOLOGY, V38, P50

← 4 5 6 7 8 9 10 11 12 13 →